• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锕系标记放射性药物的详细化学研究。

Detailed Chemistry Studies of Actinium Labeled Radiopharmaceuticals.

机构信息

Moltek A.S. Gebze Organize Sanayi, 41400 Gebze, Kocaeli, Turkey.

出版信息

Curr Radiopharm. 2022;15(1):76-83. doi: 10.2174/1874471014666210528123936.

DOI:10.2174/1874471014666210528123936
PMID:34053430
Abstract

BACKGROUND

The synthesis of Actinium derivatives was afforded by using PSMA- 617, DOTATATE peptides, and EDTMP ligand. Detailed experiments, quality control (QC), and stability studies were also well described. The radiolabelling reactions were performed in mild conditions with desirable radiochemical yields and high radiochemical purities.

METHODS

PSMA-617, DOTATATE were radiolabelled with Actinium in 0.1 M HCl in the presence of ascorbate buffer solution and passed through the C-18 light cartridge for purification and the product was eluted by ethanol-water solution. EDTMP was also radiolabelled with Actinium without using any stabilizer and purification step. All products were well analyzed by R-TLC and R-HPLC. The stability of those compounds was also studied within the validity period of time.

RESULTS

Ac-DOTATATE and 225Ac-PSMA-617 were obtained at the same condition. The radiochemical yield of 225Ac-DOTATATE was less thanAc-PSMA 617. The stability experiments indicating decay daughters of Actinium appeared after T0 +1 h due to the recoil effect radiolysis. On the other hand, Ac-EDTMP was more stable than DOTA-peptide radiolabelled compounds. Ac-EDTMP was produced with more than 95% radiochemical yield and 99% radiochemical purity.

CONCLUSION

A detailed chemistry study was presented for the synthesis of Actinium derivatives in mild conditions with absolute radiochemical purities and high yields. The experimental results showed that Ac-EDTMP could be a suitable radiopharmaceutical alternative for bone metastases arising from primer tumors as a cocktail therapy.

摘要

背景

使用 PSMA-617、DOTATATE 肽和 EDTMP 配体合成锕系元素衍生物。详细的实验、质量控制 (QC) 和稳定性研究也得到了很好的描述。放射性标记反应在温和条件下进行,具有理想的放射化学产率和高放射化学纯度。

方法

PSMA-617、DOTATATE 在 0.1 M HCl 中用锕系元素标记,在抗坏血酸缓冲溶液存在下进行,并通过 C-18 轻柱进行纯化,产物用乙醇-水溶液洗脱。EDTMP 也无需使用任何稳定剂和纯化步骤即可与锕系元素标记。所有产品均通过 R-TLC 和 R-HPLC 进行了很好的分析。还在有效期内研究了这些化合物的稳定性。

结果

在相同条件下获得了 Ac-DOTATATE 和 225Ac-PSMA-617。225Ac-DOTATATE 的放射化学产率低于 Ac-PSMA 617。稳定性实验表明,由于反冲效应辐射分解,锕系元素的衰变子在 T0 +1 h 后出现。另一方面,Ac-EDTMP 比 DOTA-肽标记化合物更稳定。Ac-EDTMP 的放射化学产率超过 95%,放射化学纯度超过 99%。

结论

在温和条件下,用绝对放射化学纯度和高收率对锕系元素衍生物的合成进行了详细的化学研究。实验结果表明,Ac-EDTMP 可以作为源自原发病灶的骨转移的鸡尾酒疗法的合适放射性药物替代品。

相似文献

1
Detailed Chemistry Studies of Actinium Labeled Radiopharmaceuticals.锕系标记放射性药物的详细化学研究。
Curr Radiopharm. 2022;15(1):76-83. doi: 10.2174/1874471014666210528123936.
2
Evaluation of [Ac]Ac-DOTA for α-Therapy of Bone Metastases.用于骨转移α治疗的[Ac]Ac-DOTA评估。
Curr Radiopharm. 2018;11(3):223-230. doi: 10.2174/1874471011666180604083911.
3
A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.综述:用于治疗目的的锕-225 标记化合物和生物分子的最新进展。
Chem Biol Drug Des. 2023 Nov;102(5):1276-1292. doi: 10.1111/cbdd.14311. Epub 2023 Sep 15.
4
Synthesis of Ac-PSMA-617 for Preclinical Use.用于临床前研究的Ac-PSMA-617的合成。
Curr Radiopharm. 2022;15(2):96-103. doi: 10.2174/1874471014666210709094616.
5
Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies.加速器生产锕系疗法用放射性药物的质量控制考虑因素。
Cancer Biother Radiopharm. 2022 Jun;37(5):355-363. doi: 10.1089/cbr.2022.0010.
6
Simple new method for labelling of PSMA-11 with Ga in NaHCO.用 NaHCO 中的 Ga 对 PSMA-11 进行标记的简单新方法。
Appl Radiat Isot. 2021 Jun;172:109692. doi: 10.1016/j.apradiso.2021.109692. Epub 2021 Mar 18.
7
Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.基于简化的 NaCl 的(68)Ga 浓度和标记程序,可实现高放射化学纯度的(68)Ga 放射性药物的快速合成。
Bioconjug Chem. 2012 Aug 15;23(8):1712-7. doi: 10.1021/bc300103t. Epub 2012 Jul 19.
8
Alpha Before Beta: Exceptional Response to First-Line 225Ac-DOTATATE in a Patient of Metastatic Neuroendocrine Tumor With Extensive Skeletal Involvement.阿尔法先于贝塔:广泛骨骼累及的转移性神经内分泌肿瘤患者一线接受 225Ac-DOTATATE 治疗后出现显著疗效。
Clin Nucl Med. 2022 Feb 1;47(2):e156-e157. doi: 10.1097/RLU.0000000000003823.
9
A Specific HPLC Method to Determine Residual HEPES in [Ga]Ga-Radiopharmaceuticals: Development and Validation.一种用于测定 [Ga]Ga 放射性药物中残留 HEPES 的特定 HPLC 方法:开发与验证。
Molecules. 2022 Jul 13;27(14):4477. doi: 10.3390/molecules27144477.
10
Development of Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences.锕系放射性药物的发展:加拿大 TRIUMF 实验室的观点与经验
Curr Radiopharm. 2018;11(3):156-172. doi: 10.2174/1874471011666180416161908.

引用本文的文献

1
Gamma counting protocols for the accurate quantification of Ac and Bi without the need for a secular equilibrium between parent and gamma-emitting daughter.用于准确量化锕(Ac)和铋(Bi)的伽马计数协议,无需母体与发射伽马射线的子体之间达到长期平衡。
EJNMMI Radiopharm Chem. 2022 Oct 23;7(1):28. doi: 10.1186/s41181-022-00174-z.